COPD Assessment Test (CAT) Global Initiative for Chronic Obstructive Pulmonary Disease’s “Could It Be COPD?” Questionnaire No COPD questionnaire is 100% accurate at predicting COPD.

A COPD assessment test (CAT) is a tool that can help you communicate the severity of your condition to your doctor. People with chronic obstructive pulmonary disease (COPD) often have difficulties ...

One of them is the COPD Assessment Test (CAT), which is a quick and easy test for patients to complete and provides a score that indicates the impact of the disease on their health status.

One of the aims of the COPD Assessment Test (CAT) is to aid communication between the physician and patient about the burden of chronic obstructive pulmonary disease (COPD) on the patient's life.

can be reliably assessed with the COPD Assessment Test™ (CAT), according to a new study from the UK. "There is currently no widely accepted standardized method for assessing symptom severity at ...

The schema newly classified 15.4% of persons without airflow obstruction as having COPD by minor diagnostic category, Surya P ...

Assessment of COPD severity was based solely on the degree of bronchial obstruction, despite a weak correlation between lung function parameters and perceived symptoms and limitations. 1 However ...

January 27, 2012 — Scores obtained at exacerbation with the chronic obstructive pulmonary disease (COPD) assessment test (CAT) are a reliable indicator of exacerbation severity and can also be ...

A high assessment test score for chronic obstructive pulmonary disease (COPD) may predict anxiety in patients, a recent study reported. A high assessment test score for chronic obstructive ...

We conducted an observational study involving 2736 current or former smokers and controls who had never smoked and measured their respiratory symptoms using the COPD Assessment Test (CAT ...

Researchers also analyzed drug safety and scores on the COPD Assessment Test (CAT), St. George’s Respiratory Questionnaire (SGRQ) and Evaluating Respiratory Symptoms in COPD (E-RS-COPD ...

More patients receiving mepolizumab vs. placebo were classified as COPD Assessment Test responders. SAN DIEGO — Among patients with COPD and heightened eosinophil levels, mepolizumab lowered ...